Stevanato Group SPA (FRA:87N) Debt-to-Equity : 0.28 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stevanato Group SPA Debt-to-Equity?

Stevanato Group SPA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €93 Mil. Stevanato Group SPA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €281 Mil. Stevanato Group SPA's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €1,330 Mil. Stevanato Group SPA's debt to equity for the quarter that ended in Mar. 2024 was 0.28.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Stevanato Group SPA's Debt-to-Equity or its related term are showing as below:

FRA:87N' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.18 Med: 0.28 Max: 1.42
Current: 0.28

During the past 6 years, the highest Debt-to-Equity Ratio of Stevanato Group SPA was 1.42. The lowest was 0.18. And the median was 0.28.

FRA:87N's Debt-to-Equity is ranked worse than
55.46% of 705 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs FRA:87N: 0.28

Stevanato Group SPA Debt-to-Equity Historical Data

The historical data trend for Stevanato Group SPA's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SPA Debt-to-Equity Chart

Stevanato Group SPA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.42

1.17

0.29

0.22

0.35

Stevanato Group SPA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial													0.22	0.18	0.27	0.35	0.28

Competitive Comparison of Stevanato Group SPA's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Stevanato Group SPA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stevanato Group SPA's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SPA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Stevanato Group SPA's Debt-to-Equity falls into.

Stevanato Group SPA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Stevanato Group SPA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(141.438	+	255.151)	/	1132.531
	=	0.35

Stevanato Group SPA's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(93.455	+	280.536)	/	1330.37
	=	0.28

Stevanato Group SPA (FRA:87N) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Stevanato Group SPA Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Stevanato Group SPA's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Stevanato Group SPA (FRA:87N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SPA (FRA:87N) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

STVN:USA

Address

Via Molinella 17, Piombino Dese, Padua, ITA, 35017

Website

https://www.stevanatogroup.com

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% from South America. It has two segments Biopharmaceutical and Diagnostic Solutions and Engineering.

Stevanato Group SPA (FRA:87N) Headlines

No Headlines